Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-25 Sale |
2025-02-26 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
884 | $480.95 | $425,160 | 9,086 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
671 | $455.06 | $305,345 | 10,798 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-12 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
1,376 | $459.83 | $632,726 | 9,953 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-03 4:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
240 | $419 | $100,560 | 7,500 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:29 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
883 | $425.7 | $375,893 | 7,965 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
1,374 | $420.24 | $577,410 | 9,676 (Direct) |
View |
| 2023-05-30 Sale |
2023-06-01 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
289 | $329.82 | $95,318 | 6,838 (Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 4:44 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
1,207 | $287.55 | $347,072 | 7,303 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
327 | $269.55 | $88,143 | 3,496 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-26 Tax Withholding |
2025-02-28 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
1,241 | $479.61 | 7,845 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
828 | $483.28 | 9,086 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
564 | $463.46 | 10,798 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
2,080 | $0 | 12,033 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
591 | $467.98 | 9,953 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
4,420 | $0 | 11,920 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-03 4:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
225 | $418.1 | 7,500 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
828 | $431.79 | 7,965 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
591 | $422.74 | 9,676 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
4,803 | $0 | 11,641 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
176 | $313.74 | 7,127 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:44 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
502 | $289.12 | 7,303 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:32 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
5,516 | $0 | 9,012 (Direct) |
View |
| 2022-04-01 Tax Withholding |
2022-04-05 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
137 | $263.09 | 3,823 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
2,566 | $0 | 3,960 (Direct) |
View |
Ownership |
2021-05-03 5:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
0 | $0 | 1,394 (Direct) |
View |